Skip to main content

Zutripro FDA Approval History

FDA Approved: Yes (First approved June 8, 2011)
Brand name: Zutripro
Generic name: chlorpheniramine, hydrocodone and pseudoephedrine
Dosage form: Oral Solution
Company: Cypress Pharmaceutical, Inc.
Treatment for: Cough and Nasal Congestion

Zutripro (chlorpheniramine, hydrocodone and pseudoephedrine) Oral Solution is a combination product containing an antitussive, an antihistamine, and a nasal decongestant indicated for the relief of cough and nasal congestion associated with the common cold and upper respiratory allergies.

Development timeline for Zutripro

Jun 22, 2011Approval FDA Approves Zutripro (hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine HCl) Oral Solution

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.